Medicus Pharma Ltd（MDCX, MDCXW）美股招股说明书 S-1 （2025-11-19首版）（英文版）（162页）.pdf

1、S-1 1 forms1.htm FORM S-1As filed with the Securities and Exchange Commission on November 19,2025.Registration No.333-UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549FORM S-1REGISTRATION STATEMENTUNDER THE SECURITIES ACT OF 1933MEDICUS PHARMA LTD.(Exact name of Registrant as speci

2、fied in its charter)_Ontario,Canada283498-1778211(State or other jurisdiction ofincorporation or organization)(Primary Standard IndustrialClassification Code Number)(I.R.S.EmployerIdentification Number)300 Conshohocken State Rd.,Suite 200W.Conshohocken,PA 19428Telephone:(610)636-0184(Address,includi

3、ng zip code,and telephone number,including area code,ofRegistrants principal executive offices)Medicus Pharma Inc.300 Conshohocken State Road,Suite 200Conshohocken,PA 19428Telephone(610)540-7515(Name,address,including zip code,and telephone number,including area code,of agent of service)Copies to:Ch

4、ristopher J.CummingsPaul,Weiss,Rifkind,Wharton&Garrison LLP1285 Avenue of the AmericasNew York,NY10019-6064Telephone:(212)373-3000Facsimile:(212)757-3990Aaron SonshineBennett Jones LLP3400 One First Canadian PlaceP.O.Box 130,Toronto,ONM5X 1A4Telephone:(416)777-6448Facsimile:(416)863-1716Approximate

5、date of commencement of proposed sale to the public:From time to time after this Registration Statementbecomes effective.If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule415 under the Securities Act,check the following box.If t

6、his Form is filed to register additional securities for an offering pursuant to Rule 462(b)under the Securities Act,checkthe following box and list the Securities Act registration statement number of the earlier effective registration statement for thesame offering.If this Form is a post-effective a